Culprit Vessel Percutaneous Coronary Intervention Versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease

被引:253
作者
Hannan, Edward L. [1 ]
Samadashvili, Zaza
Walford, Gary [2 ]
Holmes, David R., Jr. [3 ]
Jacobs, Alice K. [4 ]
Stamato, Nicholas J. [6 ]
Venditti, Ferdinand J. [5 ]
Sharma, Samin [7 ]
King, Spencer B., III [8 ]
机构
[1] SUNY Albany, Sch Publ Hlth, Rensselaer, NY 12144 USA
[2] St Josephs Hosp, Syracuse, NY USA
[3] Mayo Clin, Rochester, MN USA
[4] Boston Univ, Med Ctr, Boston, MA USA
[5] Albany Med Ctr, Albany, NY USA
[6] United Hlth Serv, Binghamton, NY USA
[7] Mt Sinai Med Ctr, New York, NY 10029 USA
[8] St Josephs Hlth Syst, Atlanta, GA USA
关键词
DRUG-ELUTING STENTS; BARE-METAL STENTS; REVASCULARIZATION; METAANALYSIS; OUTCOMES; SAFETY; SINGLE;
D O I
10.1016/j.jcin.2009.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to examine the differences in in-hospital and longer-term mortality for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease as a function of whether they underwent single-vessel (culprit vessel) percutaneous coronary interventions (PCIs) or multivessel PCI. Background The optimal treatment of patients with STEMI and multivessel disease is of continuing interest in the era of drug-eluting stents. Methods STEMI patients with multivessel disease undergoing PCIs in New York between January 1, 2003, and June 30, 2006, were subdivided into those who underwent culprit vessel PCI and those who underwent multivessel PCI during the index procedure, during the index admission, or staged within 60 days of the index admission. Patients were propensity-matched and mortality rates were calculated at 12, 24, and 42 months. Results A total of 3,521 patients (87.5%) underwent culprit vessel PCI during the index procedure. A total of 259 of them underwent staged PCI during the index admission and 538 patients underwent staged PCI within 60 days of the index procedure. For patients without hemodynamic compromise, culprit vessel PCI during the index procedure was associated with lower in-hospital mortality than multivessel PCI during the index procedure (0.9% vs. 2.4%, p = 0.04). Patients undergoing staged multivessel PCI within 60 days after the index procedure had a significantly lower 12-month mortality rate than patients undergoing culprit vessel PCI only (1.3% vs. 3.3%, p = 0.04). Conclusions Our findings support the American College of Cardiology/American Heart Association (ACC/AHA) recommendation that culprit vessel PCI be used for STEMI patients with multivessel disease at the time of the index PCI when patients are not hemodynamically compromised. However, staged PCI within 60 days after the index procedure, including during the index admission, is associated with risk-adjusted mortality rates that are comparable with the rate for culprit vessel PCI alone. (J Am Coll Cardiol Intv 2010;3:22-31) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:22 / 31
页数:10
相关论文
共 23 条
  • [1] Antman E., 2007, J AM COLL CARDIOL, V2008, P210
  • [2] Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014
  • [3] Culprit-only or multivessel revascularization in patients with acute coronary syndromes: An American College of Cardiology National Cardiovascular Database Registry report
    Brener, Sorin J.
    Milford-Beland, Sarah
    Roe, Matthew T.
    Bhatt, Deepak L.
    Weintraub, William S.
    Brindis, Ralph G.
    [J]. AMERICAN HEART JOURNAL, 2008, 155 (01) : 140 - 146
  • [4] CARLO DM, 2004, INT J CARDIOVASC INT, V34, P128
  • [5] In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction
    Chen, LY
    Lennon, RJ
    Grantham, JA
    Berger, PB
    Mathew, V
    Singh, M
    Holmes, DR
    Rihal, CS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (03) : 349 - 354
  • [6] Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction
    Corpus, RA
    House, JA
    Marso, SP
    Grantham, A
    Huber, KC
    Laster, SB
    Johnson, WL
    Daniels, WC
    Barth, CW
    Giorgi, LV
    Rutherford, BD
    [J]. AMERICAN HEART JOURNAL, 2004, 148 (03) : 493 - 500
  • [7] Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials
    De Luca, Giuseppe
    Stone, Gregg W.
    Suryapranata, Harry
    Laarman, Gerrit Jan
    Menichelli, Maurizio
    Kaiser, Christoph
    Valgimigli, Marco
    Di Lorenzo, Emilio
    Dirksen, Maurits T.
    Spaulding, Christian
    Pittl, Undine
    Violini, Roberto
    Percoco, Gianfranco
    Marino, Paolo
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 133 (02) : 213 - 222
  • [8] Gu X, 1993, J COMPUTATIONAL GRAP, V4, P405, DOI DOI 10.1080/10618600.1993.10474623
  • [9] A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty
    Hannan, EL
    Racz, MJ
    McCallister, BD
    Ryan, TJ
    Arani, DT
    Isom, OW
    Jones, RH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) : 63 - 72
  • [10] Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction
    Kastrati, Adnan
    Dibra, Alban
    Spaulding, Christian
    Laarman, Gerrit J.
    Menichelli, Maurizio
    Valgimigli, Marco
    Di Lorenzo, Emilio
    Kaiser, Christoph
    Tierala, Ilkka
    Mehilli, Julinda
    Seyfarth, Melchior
    Varenne, Olivier
    Dirksen, Maurits T.
    Percoco, Gianfranco
    Varricchio, Attilio
    Pittl, Undine
    Syvanne, Mikko
    Suttorp, Maarten J.
    Violini, Roberto
    Schoemig, Albert
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 (22) : 2706 - 2713